Methotrexate and Statins With Methotrexate Alone in the Treatment of Rheumatoid Arthritis

After approval from Board of Studies and IRB of King Edward Medical University, all patients fulfilling inclusion and exclusion criteria from out patient department and wards of Mayo Hospital Lahore will be selected and randomized to group A or group B by lottery method (using coin flipping method) with one group receiving combination of methotrexate and simvastatin and other group receiving simvastatin only. All patients will be given adequate dose of analgesics for pain relief. Informed consent will be obtained from the patient. Demographic information like name, age and sex, will also be obtained. DAS 28 scoring will be done at the time of presentation and will be noted. Patients will be followed at 1 month, 3 month and at 6 month. At each follow up DAS 28(ESR) score will be calculated using DAS 28 calculator. All this information will be recorded on predesigned proforma (attached).

Inclusion criteria

• All patients between ages 18 years and above
• Gender- Both male and female
• Fulfilling 2010 ACR/EULAR criteria of Rheumatoid arthritis with active inflammatory disease defined by DAS 28 score >2.6,
• Normal serum cholesterol level.

Exclusion criteria

• Already diagnosed patients of Diabetes mellitus.
• Use of steroids greater than 4 weeks of duration or intra articular steroid injection within 4 weeks of study.
• Statin therapy in last three months.
• Statin intolerant patient.
• Elevated Creatinine Phosphokinase more than twice the upper limit of normal range.
• Diagnosed case of Chronic liver disease or abnormal liver functions (transaminases > 2 times the upper limit of normal range) before the start of treatment or during follow-up.
• High serum Creatinine level
• Pregnancy and breast feeding.